Literature DB >> 22847502

Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike.

Mary Kay Barton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847502     DOI： 10.3322/caac.21151

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  3 in total

1.  UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Authors:  Dan Jin; Jiwei Guo; Yan Wu; Jing Du; Xiaohong Wang; Jiajia An; Baoguang Hu; Lingqun Kong; Weihua Di; Wansheng Wang
Journal:  Theranostics       Date:  2019-03-17       Impact factor: 11.556

2.  The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

Authors:  Jiwei Guo; Dan Jin; Yan Wu; Lijuan Yang; Jing Du; Kaikai Gong; Weiwei Chen; Juanjuan Dai; Shuang Miao; Sichuan Xi
Journal:  EBioMedicine       Date:  2018-08-23       Impact factor: 8.143

3.  Lung cancer in patients with and without rheumatoid arthritis: A propensity score-matched survival analysis cohort study.

Authors:  Lei Zhang; Qiliang Zhao; Fan Yuan; Min Liu
Journal:  Thorac Cancer       Date:  2020-03-27       Impact factor: 3.500
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.